Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
about
Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccineImmunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.Novel antigen delivery systems.Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer.Delivery strategies for novel vaccine formulations.Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populationsVirus-like particle vaccines and adjuvants: the HPV paradigm.Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins.Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity.The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine.Hepatitis B Surface Antigen S Gene is an Effective Carrier Molecule for Developing GnRH DNA Immunocastration Vaccine in Mice.Vanadium pentoxide inhalation provokes germinal center hyperplasia and suppressed humoral immune responses.Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection.
P2860
Q33359620-CB751B18-AB11-4488-91E0-DCC15B4ACEC4Q35739112-049EAB03-9D51-4227-BFDE-A0534B1218D5Q35947894-49812C0A-7876-4EEE-B85C-6FA0A97A2C68Q36424493-6D81BF8B-3F31-422D-BB24-4D941C1B930AQ36897382-BBA12CE8-94C3-4848-8521-72F4DF01F4C4Q37195521-3EF737EF-8B42-48EF-88D3-3CD909017DC8Q37247481-96624CDA-C0C5-4170-BFA2-256AE90850C5Q37608311-CDB0365F-6350-4066-B81D-F273374E9AECQ39779815-5CD1CCFA-723F-4BB5-BDD9-2037C59DAC78Q41877558-B4CEF0D2-ADDA-4E9E-AE00-A6C201258420Q45324462-EFC650D6-D929-4803-8409-62C36C3E843DQ47873692-1E4A5D42-6323-4C95-AD6E-8329347C8A77Q50644992-04F4EB10-83F9-464B-B423-36CBDA2316C0Q51050741-FCE3646E-41BA-4B6E-94F7-84293B268AB2
P2860
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@en
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@nl
type
label
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@en
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@nl
prefLabel
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@en
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@nl
P2093
P2860
P1433
P1476
Hepatitis B surface antigen ve ...... ase-relevant foreign epitopes.
@en
P2093
Hans-Jürgen Netter
Karen A Herd
Robert W Tindle
Tracy Doan
Wai-Ping Woo
P2860
P304
P356
10.1128/JVI.80.8.3975-3984.2006
P407
P577
2006-04-01T00:00:00Z